<i>TRAF3</i> alterations are frequent in del‐3′ <scp>IGH</scp> chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features-Reference-Cited by-同舟云学术

TRAF3 alterations are frequent in del‐3′ IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

Published:2022-05-09 Issue:7 Volume:97 Page:903-914
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Pérez‐Carretero Claudia¹²^ORCID,Hernández‐Sánchez María¹²,González Teresa¹²,Quijada‐Álamo Miguel¹²,Martín‐Izquierdo Marta¹²^ORCID,Santos‐Mínguez Sandra¹²,Miguel‐García Cristina¹²,Vidal María‐Jesús³,García‐De‐Coca Alfonso⁴,Galende Josefina⁵,Pardal Emilia⁶^ORCID,Aguilar Carlos⁷,Vargas‐Pabón Manuel⁸,Dávila Julio⁹^ORCID,Gascón‐Y‐Marín Isabel¹⁰,Hernández‐Rivas José‐Ángel¹⁰,Benito Rocío¹²,Hernández‐Rivas Jesús‐María¹²^ORCID,Rodríguez‐Vicente Ana‐Eugenia¹²^ORCID

Affiliation:

1. Universidad de Salamanca, IBSAL, IBMCC‐ Centro de Investigación del Cáncer (USAL‐CSIC) Salamanca Spain

2. Servicio de Hematología Hospital Universitario de Salamanca Salamanca Spain

3. Servicio de Hematología Hospital Universitario León Spain

4. Servicio de Hematología Hospital Clínico Valladolid Spain

5. Servicio de Hematología Hospital El Bierzo Ponferrada Spain

6. Servicio de Hematología Hospital Virgen del Puerto Plasencia Spain

7. Servicio de Hematología, Complejo Hospitalario de Soria Soria Spain

8. Servicio de Hematología Hospital Jarrio Asturias Spain

9. Servicio de Hematología Hospital Nuestra Señora de Sonsoles Ávila Spain

10. Servicio de Hematología, Hospital Universitario Infanta Leonor Universidad Complutense Madrid Spain

Funder

Universidad de Salamanca

Fundación Española de Hematología y Hemoterapia

Centro de Investigación Biomédica en Red de Cáncer

Consejería de Educación, Junta de Castilla y León

European Regional Development Fund

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26578

Reference59 articles.

1. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia

2. Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B‐cell chronic lymphocytic leukemia;Berkova A;Neoplasma,2008

3. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia

4. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL

5. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

2. First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes;International Journal of Hematology;2023-03-19

3. Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4;The Journal of Immunology;2023-03-08

4. TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes;Frontiers in Oncology;2023-01-27